News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Starts Construction On $300 Million China Plant


4/18/2014 11:54:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

April 18, 2014 -- Johnson & Johnson broke ground yesterday on a $300 million facility in the Xi'an High-tech Development Zone. For J&J, the new facility is its biggest single investment in a plant and its largest production facility (2.9 million square feet). It will house an innovation center for J&J's Asian supply chain, the largest production capacity for vaccines in Asia, and a registration center for foreign biomedical projects. Construction will be completed in 2018. More details....

Stock Symbol: (NYSE: JNJ)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES